CCM
ABBV icon

Charter Capital Management’s AbbVie ABBV Stock Holding History

Charter Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
986
+1
+0.1% +$215 0.11% 61
2026
Q1 		$214K Buy
+985
New +$218K 0.11% 66

Other funds holding ABBV

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Charter Capital Management's ABBV Position: Q2 2026 in Review

Charter Capital Management increased its AbbVie (ABBV) stake by 0.1% in Q2 2026, buying an estimated $215 and bringing the position to 986 shares worth $248K. The position accounts for 0.11% of the portfolio, ranked #61.

Charter Capital Management first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Charter Capital Management held 986 shares of AbbVie worth $248K as of Q2 2026.
  • Charter Capital Management bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.11% of Charter Capital Management's portfolio in Q2 2026, its #61 holding.
  • Charter Capital Management first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Charter Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.